PRESSRELEASES
28 April, 2022
The European Patent Office has granted Nanexa’s PharmaShell® patent
Nanexa AB (publ) today announced that the European Patent Office (EPO) has granted the company’s patent application relating to the drug delivery system PharmaShell®. The patent protection covers the manufacturing method of PharmaShell and products produced using the method.
20 April, 2022
Nanexa publishes interim report for January – March 2022
Positive development in the product projects and in the patent portfolio
LATEST REPORTS
CURRENT
2 maj, 2022
Aktiespararna, Aktiedagen Stockholm
20 mars, 2022
Webcast och frågestund, Delårsrapport jan-mar 2022
NEWSLETTER
